A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function

Thrombosis and Haemostasis

Volumn 111, Issue 1, 2013, Pages 79-87

  Riedelová Reicheltová, Zuzana ^a   Kotlín, Roman ^a   Suttnar, Jiří ^a   Geierová, Všra ^a   Riedel, Tomáš ^a   Májek, Pavel ^a   Dyr, Jan Evangelista ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Fibrinogen; Platelet aggregation; Pregnancy loss; RGD sequence; Thrombosis

Indexed keywords

FIBRIN; FIBRINOPEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; FEMALE; FIBRINOGEN DEFECT; FIBRINOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MOLECULAR MODEL; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN POLYMERIZATION; PROTEIN PURIFICATION; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE AGGREGATION;

FIBRINOGEN; PLATELET AGGREGATION; PREGNANCY LOSS; RGD SEQUENCE; THROMBOSIS;

ABORTION, SPONTANEOUS; ADULT; BATROXOBIN; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FEMALE; FIBRIN; FIBRINOGEN; FIBRINOLYSIS; HETEROZYGOTE; HUMANS; PLATELET AGGREGATION; POINT MUTATION; PREGNANCY; PROTEIN CONFORMATION; THROMBIN; THROMBOPHILIA; TIME FACTORS;

EID: 84891886454     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-04-0267     Document Type: Article

References (31)

1. Weisel JW. Fibrinogen and fibrin. Adv Prot Chem 2005; 70: 247-299.
2. Hill M, Dolan G. Diagnosis, clinical features and molecular assessment of the dysfibrinogeneamias. Haemophilia 2008; 14: 889-897.
3. Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost 2006; 4: 2115-2129.
4. Okumura N, Terasawa F, Hirota-Kawadobora M, et al. A novel variant fibrinogen, deletion of Bβ111Ser in coiled-coil region, affecting fibrin lateral aggregation. Clin Chim Acta 2006; 365: 160-167.
5. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-1904.
6. Kotlín R, Reicheltová Z, Suttnar J, et al. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo. J Thromb Thrombolysis 2010; 30: 311-318.
7. Brennan SO, Hammonds B, George PM. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val--> Asp). J Clin Invest 1995; 96: 2854-2858.
8. Suttnar J, Dyr JE, Fortová H, et al. Determination of fibrinopeptides by high performance liquid chromatography. Biochem Clin Bohemoslov 1989; 18: 17-25.
9. Kotlín R, Sobotková A, Suttnar J, et al. A novel fibrinogen variant-Liberec: dysfibrinogenaemia associated with γ Tyr262Cys substitution. Eur J Haematol 2008; 81: 123-129.
10. Miller SA, Dykes PD, Polensky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988; 16: 1215.
11. Riedel T, Brynda E, Dyr JE, et al. Controlled preparation of thin fibrin films immobilized at solid surfaces. J Biomed Mater Res A 2009; 88A: 437-447.
12. Reicheltova Z, Majek P, Riedel T, et al. Simplified platelet sample preparation for SDS-PAGE-based proteomic studies. Proteomics Clin Appl 2012; 6: 374-381.
13. Majek P, Reicheltova Z, Stikarova J, et al. Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin. Proteome Sci 2010; 8: 56.
14. Kollman JM, Pandi L, Sawaya MR, et al. Crystal structure of human fibrinogen. Biochemistry 2009; 48: 3977-3986.
15. Dear A, Brennan SO, Dempfle CE, et al. Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala-->Val substitution (fibrinogen Dorfen). Thromb Haemost 2004; 92: 1291-1295.
16. Undas A, Zdziarska J, Iwaniec T, et al. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function. Thromb Haemost 2009; 101: 975-976.
17. Takagi T, Doolittle RF. Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: N-terminal sequence of intermediate and terminal fragments. Biochemistry 1975; 14: 940.
18. Lugovskoy EV, Gritsenko PG, Kolesnikova IN, et al. A neoantigenic determinant in coiled coil region of human fibrin β-chain. Thromb Res 2009; 123: 765-770.
19. Sugo T, Nakamikawa C, Takano H, et al. Fibrinogen Niigata with impaired fibrin assembly: an inherited dysfibrinogen with a Bbeta Asn-160 to Ser substitution associated with extra glycosylation at Bbeta Asn-158. Blood 1999; 94: 3806-3813.
20. Lounes KC, Lefkowitz JB, Henschen-Edman AH, et al. The impaired polymerization of fibrinogen Longmont (Bbeta 166 Arg→Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cystein-linked monomers. Blood 2001; 98: 661-667.
21. Soe G, Kohno I, Inuzuka K, et al. A monoclonal antibody that recognizes a neoantigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma. Blood 1996; 88: 2109-2117.
22. Morris TA, Marsh JJ, Chiles PG, et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 2009; 114: 1929-1936.
23. Doolittle RF. Determining the crystal structure of fibrinogen. J Thromb Haemost 2004; 2: 683-689.
24. Hunter CA, Singh J, Thornton JM. π-π interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins. J Mol Biol 1991; 218: 837-846.
25. Marchi R, Arocha-Piñango CL, Nagy H, et al. The effects of additional carbohydrate in the coiled-coil region of fibrinogen on polymerization and clot structure and properties: characterization of the homozygous and heterozygous forms of fibrinogen Lima (Aα Arg141→Ser with extra glycosylation). J Thromb Haemost 2004; 2: 940-948.
26. Cheresh DA, Berliner SA, Vicente V, et al. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989; 58: 945-953.
27. Farrell DH, Thiagarajan P, Chung DW, et al. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992; 89: 10729-10732.
28. Kotlín R, Reicheltová Z, Malý M, et al. Two cases of congenital dysfibrinogenemia associated with thrombosis-Fibrinogen Praha III a Fibrinogen Plzen. Thromb Haemost 2009; 102: 479-486.
29. Collet JP, Allali Y, Lesty C, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006; 26: 2567-2573.
30. Krabbendam I, Franx A, Bots ML, et al. Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol 2005; 118: 143-153.
31. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995; 73: 151-161.